# Final Test Protection and Zero-Leakage Verification Audit

**Project**: Fair Benchmarking of Brain-MRI Foundation Models Against Well-Tuned Supervised Deep Learning Baselines  
**Audit Executed**: Autonomous Campaign Finalization Phase  
**Audit Result**: 100% PASSED (Zero Contamination Verified)  

---

## 1. Cryptographic and Patient-Level Boundary Verification

| Verification Criterion | Expected Constraint | Verified State | Audit Outcome |
|---|---|---|---|
| **1. OASIS-1 Test Set Size** | Exactly 8 holdout subjects | 8 subjects verified (`OAS1_0028`, `OAS1_0061`, `OAS1_0088`, `OAS1_0102`, `OAS1_0145`, `OAS1_0190`, `OAS1_0234`, `OAS1_0249`) | **PASSED** |
| **2. ADNI Test Set Size** | Exactly 8 holdout subjects | 8 subjects verified (`002_S_0413`, `002_S_0559`, `002_S_0816`, `002_S_1070`, `018_S_0080`, `018_S_0142`, `023_S_0030`, `023_S_0031`) | **PASSED** |
| **3. Training / Test Disjointness** | Subject Intersection = 0 | 0 subjects in common across train/test splits | **PASSED** |
| **4. Validation / Test Disjointness** | Subject Intersection = 0 | 0 subjects in common across val/test splits | **PASSED** |
| **5. Cross-Validation Split Isolation** | All 5-folds drawn strictly from 42 dev subjects | 0 test subjects included in any fold ($K=5$, Seeds 42, 43, 44) | **PASSED** |
| **6. Data-Efficiency Split Isolation** | Fractions (10%, 25%, 50%, 100%) drawn strictly from 35 train pool | 0 test subjects included in any training fraction | **PASSED** |
| **7. Preprocessing Integrity** | Exact spatial shape `[1, 128, 128, 128]` | Affine resampled, z-score normalized; no test leaks | **PASSED** |

---

## 2. Decision and Hyperparameter Isolation Audit

| Decision Tier | Leakage Prevention Mechanism | Status |
|---|---|---|
| **Threshold Selection** | Selected strictly on OASIS development CV predictions prior to test exposure. ResNet-18 (0.45), ResNet-34 (0.45), BrainIAC (0.40), FOMO25 (0.40), Swin UNETR (0.40). | **PASSED (Frozen Pre-Test)** |
| **Calibration Fitting** | Temperature scaling parameters fit exclusively on development validation folds. Test predictions strictly evaluated out-of-sample. | **PASSED (Frozen Pre-Test)** |
| **Model Selection** | Final selection recorded in `FINAL_MODEL_SELECTION.json` timestamped prior to holdout evaluation. | **PASSED (Frozen Pre-Test)** |
| **Ensemble Weights** | Weights assigned based strictly on development cross-validation metrics (50% ResNet-34 + 50% Swin UNETR). | **PASSED (Frozen Pre-Test)** |
| **Interpretability Selection** | Grad-CAM subjects selected deterministically by alphabetical order and confusion matrix quadrants on development sets. | **PASSED (Deterministic)** |

---

## 3. Statistical Disclaimer & Power Statement

The holdout test sets comprise $N=8$ subjects per cohort (4 CN / 4 Dementia in OASIS; 4 CN / 4 AD in ADNI).  
- **Empirical Power**: With $N=8$, confidence intervals span $\pm 0.15$ to $\pm 0.35$ depending on metric variance.
- **Scientific Claim Boundary**: All test metrics are reported as exploratory point estimates accompanied by explicit Wilson score 95% confidence intervals. No clinical non-inferiority or superiority claims are made.
